Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

NCT05664919 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

7000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SA58 Nasal Spray

Sponsor

Sinovac Life Sciences Co., Ltd.